We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare (HCA) Q1 Earnings and Revenue Beat Estimates
Read MoreHide Full Article
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) ) performed in Q1 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Beat Estimates
HCA Healthcare came out with adjusted earnings per share of $2.97 per share, surpassing the Zacks Consensus Estimate by 28.6%. Earnings shot up nearly 27.5% year over year.
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $10.01 per share over the last 7 days.
Revenue Beat Estimates
HCA Healthcare generated revenues of $12.5 billion, beating the Zacks Consensus Estimate by 1.7%. The top line was also up 9.6% from the year-ago period.
Key Stats to Note
Adjusted EBITDA totaled $2.5 billion, up 20% year over year.
Same facility admissions and equivalent admissions were up by 0.9% and 1.8%, respectively in the quarter under review. Same facility revenue per equivalent admission grew 4.4%.
Expenses escalated nearly 7.2% year over year to $9.9 billion.
As of Mar 31, 2019, HCA Healthcare operated 185 hospitals and around 2000 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
The company bought back shares worth $278 million.
Guidance for 2019
Revenues of the company are now expected to range from $50.5 to $51.5 billion.
Adjusted EBITDA of the company is projected to be between $9.45 and $9.85 billion, up from previous guidance of $9.35 billion and $9.75 billion.
EPS is assumed to be $9.80 to $10.40 per diluted share, higher than earlier projection of $9.60 and $10.20 per share.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
Check back later for our full write up on this HCA Healthcare earnings report!
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Image: Bigstock
HCA Healthcare (HCA) Q1 Earnings and Revenue Beat Estimates
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) ) performed in Q1 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Beat Estimates
HCA Healthcare came out with adjusted earnings per share of $2.97 per share, surpassing the Zacks Consensus Estimate by 28.6%. Earnings shot up nearly 27.5% year over year.
HCA Healthcare, Inc. Price and EPS Surprise
HCA Healthcare, Inc. Price and EPS Surprise | HCA Healthcare, Inc. Quote
How Was the Estimate Revision Trend?
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $10.01 per share over the last 7 days.
Revenue Beat Estimates
HCA Healthcare generated revenues of $12.5 billion, beating the Zacks Consensus Estimate by 1.7%. The top line was also up 9.6% from the year-ago period.
Key Stats to Note
Adjusted EBITDA totaled $2.5 billion, up 20% year over year.
Same facility admissions and equivalent admissions were up by 0.9% and 1.8%, respectively in the quarter under review. Same facility revenue per equivalent admission grew 4.4%.
Expenses escalated nearly 7.2% year over year to $9.9 billion.
As of Mar 31, 2019, HCA Healthcare operated 185 hospitals and around 2000 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
The company bought back shares worth $278 million.
Guidance for 2019
Revenues of the company are now expected to range from $50.5 to $51.5 billion.
Adjusted EBITDA of the company is projected to be between $9.45 and $9.85 billion, up from previous guidance of $9.35 billion and $9.75 billion.
EPS is assumed to be $9.80 to $10.40 per diluted share, higher than earlier projection of $9.60 and $10.20 per share.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this HCA Healthcare earnings report!
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>